Georgia
Provider Communications
Anthem clinical criteria updates for specialty pharmacy are available
ING-CC-0029 |
Dupixent (dupilumab) |
ING-CC-0208 |
Adbry (tralokinumab) |
ING-CC-0214 |
Carvykti (ciltacabtagene autoleucel) |
Access the clinical criteria document information.
Anthem’s prior authorization clinical review of non-oncology specialty pharmacy drugs will be managed by Anthem’s medical specialty drug review team. Drugs used for the treatment of oncology will be managed by AIM Specialty Health® (AIM).
Featured In:
June 2022 Anthem Provider News - Georgia